|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 15
Zeitschriftenartikel
Wang, Katharina 
ORCID: https://orcid.org/0000-0002-7795-1395; Schütze, Ina; Gulde, Sebastian; Bechmann, Nicole ORCID: https://orcid.org/0000-0002-6932-333X; Richter, Susan ORCID: https://orcid.org/0000-0002-3549-2477; Helm, Jana; Lauseker, Michael; Maurer, Julian; Reul, Astrid; Spoettl, Gerald; Klink, Barbara; William, Doreen; Knösel, Thomas; Friemel, Juliane; Bihl, Michel ORCID: https://orcid.org/0000-0002-5884-739X; Weber, Achim; Fankhauser, Maria; Schober, Laura; Vetter, Diana; Broglie Däppen, Martina; Ziegler, Christian G ORCID: https://orcid.org/0000-0002-4345-696X; Ullrich, Martin ORCID: https://orcid.org/0000-0001-6104-6676; Pietzsch, Jens; Bornstein, Stefan R; Lottspeich, Christian; Kroiss, Matthias ORCID: https://orcid.org/0000-0002-7628-3161; Fassnacht, Martin; Wenter, Vera Ursula Julia ORCID: https://orcid.org/0000-0001-7385-5702; Ladurner, Roland; Hantel, Constanze; Reincke, Martin ORCID: https://orcid.org/0000-0002-9817-9875; Eisenhofer, Graeme; Grossman, Ashley B; Pacak, Karel ORCID: https://orcid.org/0000-0002-3541-3767; Beuschlein, Felix ORCID: https://orcid.org/0000-0001-7826-3984; Auernhammer, Christoph J; Pellegata, Natalia S und Nölting, Svenja ORCID: https://orcid.org/0000-0002-7064-590X
(2022):
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.
In: Endocrine-Related Cancer, Bd. 29, Nr. 6: S. 285-306
ORCID: https://orcid.org/0000-0002-7795-1395; Schütze, Ina; Gulde, Sebastian; Bechmann, Nicole ORCID: https://orcid.org/0000-0002-6932-333X; Richter, Susan ORCID: https://orcid.org/0000-0002-3549-2477; Helm, Jana; Lauseker, Michael; Maurer, Julian; Reul, Astrid; Spoettl, Gerald; Klink, Barbara; William, Doreen; Knösel, Thomas; Friemel, Juliane; Bihl, Michel ORCID: https://orcid.org/0000-0002-5884-739X; Weber, Achim; Fankhauser, Maria; Schober, Laura; Vetter, Diana; Broglie Däppen, Martina; Ziegler, Christian G ORCID: https://orcid.org/0000-0002-4345-696X; Ullrich, Martin ORCID: https://orcid.org/0000-0001-6104-6676; Pietzsch, Jens; Bornstein, Stefan R; Lottspeich, Christian; Kroiss, Matthias ORCID: https://orcid.org/0000-0002-7628-3161; Fassnacht, Martin; Wenter, Vera Ursula Julia ORCID: https://orcid.org/0000-0001-7385-5702; Ladurner, Roland; Hantel, Constanze; Reincke, Martin ORCID: https://orcid.org/0000-0002-9817-9875; Eisenhofer, Graeme; Grossman, Ashley B; Pacak, Karel ORCID: https://orcid.org/0000-0002-3541-3767; Beuschlein, Felix ORCID: https://orcid.org/0000-0001-7826-3984; Auernhammer, Christoph J; Pellegata, Natalia S und Nölting, Svenja ORCID: https://orcid.org/0000-0002-7064-590X
(2022):
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.
In: Endocrine-Related Cancer, Bd. 29, Nr. 6: S. 285-306
Bösch, Florian ORCID: https://orcid.org/0000-0002-0250-9017; Altendorf-Hofmann, Annelore; Koliogiannis, Vanessa; Ilhan, Harun; Jacob, Sven; Pretzsch, Elise; Nölting, Svenja; Werner, Jens; Klauschen, Frederick; Auernhammer, Christoph J.; Angele, Martin K. und Knösel, Thomas
(2022):
Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 5: S. 1895-1903
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-0250-9017; Altendorf-Hofmann, Annelore; Koliogiannis, Vanessa; Ilhan, Harun; Jacob, Sven; Pretzsch, Elise; Nölting, Svenja; Werner, Jens; Klauschen, Frederick; Auernhammer, Christoph J.; Angele, Martin K. und Knösel, Thomas
(2022):
Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 5: S. 1895-1903
[PDF, 1MB]
Li, Minghao; Prodanov, Tamara; Meuter, Leah; Kerstens, Michiel N.; Bechmann, Nicole; Prejbisz, Aleksander; Remde, Hanna; Timmers, Henri J. L. M.; Nölting, Svenja; Talvacchio, Sara; Berends, Annika M. A.; Fliedner, Stephanie; Robledo, Mercedes; Lenders, Jacques W. M.; Pacak, Karel; Eisenhofer, Graeme und Pamporaki, Christina
(2022):
Recurrent Disease in Patients With Sporadic Pheochromocytoma and Paraganglioma.
In: Journal of Clinical Endocrinology & Metabolism, Bd. 108, Nr. 2: S. 397-404
Jin, Xi-Feng; Spöttl, Gerald; Maurer, Julian; Nölting, Svenja und Auernhammer, Christoph Josef
(2021):
Antitumoral Activity of the MEK Inhibitor Trametinib (TMT212) Alone and in Combination with the CDK4/6 Inhibitor Ribociclib (LEE011) in Neuroendocrine Tumor Cells In Vitro.
In: Cancers, Bd. 13, Nr. 6, 1485
Remde, Hanna und Nölting, Svenja
(2021):
Phäochromozytom – Modellerkrankung für die personalisierte Medizin.
In: Deutsche Medizinische Wochenschrift, Bd. 146, Nr. 23: S. 1520-1526
Fankhauser, Maria; Bechmann, Nicole; Lauseker, Michael; Goncalves, Judith; Favier, Judith; Klink, Barbara; William, Doreen; Gieldon, Laura; Maurer, Julian; Spöttl, Gerald; Rank, Petra; Knösel, Thomas; Orth, Michael; Ziegler, Christian G.; Aristizabal Prada, Elke Tatjana; Rubinstein, German; Fassnacht, Martin; Spitzweg, Christine; Grossman, Ashley B.; Pacak, Karel; Beuschlein, Felix; Bornstein, Stefan R.; Eisenhofer, Graeme; Auernhammer, Christoph J.; Reincke, Martin und Nölting, Svenja
(2019):
Synergistic Highly Potent Targeted Drug Combinations in different Pheochromocytoma Models including Human Tumor Cultures.
In: Endocrinology, Bd. 160, Nr. 11: S. 2600-2617
Aristizabal Prada, Elke Tatjana; Weis, Carla; Orth, Michael; Lauseker, Michael; Spöttl, Gerald; Maurer, Julian; Grabowski, Patricia; Grossman, Ashley; Auernhammer, Christoph Josef und Nölting, Svenja
(2. Oktober 2018):
GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors?
In: Neuroendocrinology, Bd. 106, Nr. 4: S. 335-351
Aristizabal Prada, Elke Tatjana; Spöttl, Gerald; Maurer, Julian; Lauseker, Michael; Koziolek, Eva Jolanthe; Schrader, Jörg; Grossman, Ashley; Pacak, Karel; Beuschlein, Felix; Auernhammer, Christoph Joseph und Nölting, Svenja
(2018):
The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance.
In: Endocrine-Related Cancer, Bd. 25, Nr. 10: S. 893-908
Auernhammer, Christoph J.; Spitzweg, Christine; Angele, Martin K.; Böck, Stefan; Grossman, Ashley; Nölting, Svenja; Ilhan, Harun; Knösel, Thomas; Mayerle, Julia; Reincke, Martin ORCID: https://orcid.org/0000-0002-9817-9875 und Bartenstein, Peter
(2018):
Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies.
In: Lancet Diabetes & Endocrinology, Bd. 6, Nr. 5: S. 404-415
ORCID: https://orcid.org/0000-0002-9817-9875 und Bartenstein, Peter
(2018):
Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies.
In: Lancet Diabetes & Endocrinology, Bd. 6, Nr. 5: S. 404-415
Nölting, Svenja; Rentsch, Jakob; Freitag, Helma; Detjen, Katharina; Briest, Franziska; Möbs, Markus; Weissmann, Victoria; Siegmund, Britta; Auernhammer, Christoph J.; Prada, Elke Tatjana Aristizabal; Lauseker, Michael; Grossman, Ashley; Exner, Samantha; Fischer, Christian; Schrader, Jörg und Grabowski, Patricia
(2017):
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
In: PLoS ONE 12(8), e0182852 [PDF, 8MB]
In: PLoS ONE 12(8), e0182852 [PDF, 8MB]
Prada, Elke Tatjana Aristizabal; Orth, Michael; Nölting, Svenja; Spöttl, Gerald; Maurer, Julian und Auernhammer, Christoph
(2017):
The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells.
In: PLOS One 12(5), e0178375 [PDF, 15MB]
In: PLOS One 12(5), e0178375 [PDF, 15MB]
Angelousi, Anna; Dimitriadis, Georgios K.; Zografos, Georgios; Nölting, Svenja; Kaltsas, Gregory und Grossman, Ashley
(2017):
Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies.
In: Endocrine-Related Cancer, Bd. 24, Nr. 6:
R239-R259
Reuther, Clemens; Heinzle, Vera; Spampatti, Matilde; Vlotides, George; De Toni, Enrico; Spöttl, Gerald; Maurer, Julian; Nölting, Svenja; Göke, Burkhard und Auernhammer, Christoph J.
(2016):
Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition.
In: Neuroendocrinology, Bd. 103, Nr. 3-4: S. 383-401
[PDF, 916kB]
Nölting, Svenja; Giubellino, Alessio; Tayem, Yasin; Young, Karen; Lauseker, Michael; Bullova, Petra; Schovanek, Jan; Anver, Miriam; Fliedner, Stephanie; Korbonits, Marta; Göke, Burkhard; Vlotides, George; Grossman, Ashley und Pacak, Karel
(Juli 2014):
Combination of 13-Cis Retinoic Acid and Lovastatin: Marked Antitumor Potential In Vivo in a Pheochromocytoma Allograft Model in Female Athymic Nude Mice.
In: Endocrinology, Bd. 155, Nr. 7: S. 2377-2390
Nölting, Svenja; Kuttner, Axel; Lauseker, Michael; Vogeser, Michael; Haug, Alexander; Herrmann, Karin A.; Hoffmann, Johannes N.; Spitzweg, Christine; Göke, Burkhard und Auernhammer, Christoph J.
(2012):
Chromogranin A as serum marker for gastroenteropancreatic neuroendocrine tumors: a single center experience and literature review.
In: Cancers, Bd. 4, Nr. 1: S. 141-155
[PDF, 158kB]